Literature DB >> 24926068

Validation is a dish oft served cold.

David B Wilson1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24926068      PMCID： PMC4055917          DOI： 10.1182/blood-2014-05-572925

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice.

Authors:  F Liu; H Y Wu; R Wesselschmidt; T Kornaga; D C Link
Journal:  Immunity       Date:  1996-11       Impact factor: 31.745

2.  Inherited biallelic CSF3R mutations in severe congenital neutropenia.

Authors:  Alexa Triot; Päivi M Järvinen; Juan I Arostegui; Dhaarini Murugan; Naschla Kohistani; José Luis Dapena Díaz; Tomas Racek; Jacek Puchałka; E Michael Gertz; Alejandro A Schäffer; Daniel Kotlarz; Dietmar Pfeifer; Cristina Díaz de Heredia Rubio; Mehmet Akif Ozdemir; Turkan Patiroglu; Musa Karakukcu; José Sánchez de Toledo Codina; Jordi Yagüe; Ivo P Touw; Ekrem Unal; Christoph Klein
Journal:  Blood       Date:  2014-04-21       Impact factor: 22.113

3.  A truncation mutant of Csf3r cooperates with PML-RARα to induce acute myeloid leukemia in mice.

Authors:  Ghada Kunter; Jill R Woloszynek; Daniel C Link
Journal:  Exp Hematol       Date:  2011-09-10       Impact factor: 3.084

4.  Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey.

Authors:  Manuela Germeshausen; Matthias Ballmaier; Karl Welte
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

Review 5.  Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes.

Authors:  Christoph Klein
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

6.  The WSXWS motif in cytokine receptors is a molecular switch involved in receptor activation: insight from structures of the prolactin receptor.

Authors:  Robert Dagil; Maiken J Knudsen; Johan G Olsen; Charlotte O'Shea; Magnus Franzmann; Vincent Goffin; Kaare Teilum; Jens Breinholt; Birthe B Kragelund
Journal:  Structure       Date:  2012-02-08       Impact factor: 5.006

7.  Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.

Authors:  Jun Xia; Audrey A Bolyard; Elin Rodger; Steve Stein; Andrew A Aprikyan; David C Dale; Daniel C Link
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

8.  Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.

Authors:  Lawrence J Druhan; Jing Ai; Pam Massullo; Tamila Kindwall-Keller; Mark A Ranalli; Belinda R Avalos
Journal:  Blood       Date:  2004-09-07       Impact factor: 22.113

9.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

10.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

Authors:  G J Lieschke; D Grail; G Hodgson; D Metcalf; E Stanley; C Cheers; K J Fowler; S Basu; Y F Zhan; A R Dunn
Journal:  Blood       Date:  1994-09-15       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.